Get 20% lifetime commission for referring investors to digrin.com here.

Third Harmonic Bio, Inc. (THRD) Financials

Stock symbol THRD is outdated, potentially delisted? Maybe it is available on other exchange?

THRD Assets vs Liabilities

Date	Assets	Liabilities
Sept. 30, 2023	282.3 million	9.3 million
June 30, 2023	285.8 million	7.8 million
March 31, 2023	291.4 million	8.7 million
Dec. 31, 2022	298.7 million	9.6 million

THRD Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
Sept. 30, 2023	-4.2 million	2.3 million
June 30, 2023	-4.1 million	2.8 million
March 31, 2023	-6.7 million	2.7 million
Dec. 31, 2022	-9.3 million	2.1 million

THRD Net Income

No data available :(

THRD Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
Sept. 30, 2023	273.9 million	-	4.1 million
June 30, 2023	278.1 million	-	4.3 million
March 31, 2023	282.2 million	-	4.4 million
Dec. 31, 2022	288.9 million	-	4.3 million

THRD Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
Sept. 30, 2023	39.7 million
June 30, 2023	39.6 million
March 31, 2023	22.8 million
Dec. 31, 2022	13.4 million

THRD Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
Sept. 30, 2023	-	6.0 million	4.9 million	-
June 30, 2023	168000	5.3 million	5.4 million	-
March 31, 2023	168000	6.7 million	5.3 million	-
Dec. 31, 2022	36000	9.3 million	4.3 million	-

THRD Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
Sept. 30, 2023	-	178000
June 30, 2023	-	168000
March 31, 2023	-	72000
Dec. 31, 2022	-	38000

THRD

Price: $5.38

52 week price:

3.18

16.02

Earnings Per Share: -1.24 USD

P/E Ratio: -4.34

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 101800

Market Capitalization: 242.8 million

Links:

THRD on Yahoo Finance